Table 1. Frequency of clinicopathologic characteristics of the patients included in the study.

Characteristic	Lung adenocarcinoma (N=41)	Malignant mesothelioma (N=61)
Age (years), median	65	59
Sex, n (%)a
Female	17 (41.5)	18 (29.5)
Male	22 (53.7)	43 (70.5)
Tumor stage†, n (%)
I	17 (41.5)	–
II	14 (34.1)	–
III	5 (12.2)	–
IV	5 (12.2)	61 (100.0)
Nodal status†, n (%)b
N0	21 (51.2)	–
N1	15 (36.6)	–
Status, n (%)
Death	26 (63.4)	36 (59.0)

^†, according to the International Association for the Study of Lung Cancer (1,23,24). ^a, in 2 patients with LUAD we did not find information about your gender; ^b, in 5 patients with LUAD we did not find information about the lymph nodes status.